
Avomira 50mg Tablet ER
Marketer
Micro Labs Ltd
Salt Composition
Mirabegron (50mg)
Overview Avomira 50mg Tablet ER
Miravol ER 50mg tablets alleviate overactive bladder symptoms such as frequent urination, urgency, and incontinence. This medication relaxes bladder muscles, improving urinary capacity. Always follow your physician's prescribed dosage and duration; it may be taken with or without food. Swallow the tablet whole—do not crush or chew. Discontinue use only under medical supervision, as abrupt cessation may exacerbate symptoms. Complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infection, tachycardia, and arthralgia. Report persistent or bothersome side effects immediately to your doctor. Before starting treatment, disclose all current medications and any existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require careful monitoring and regular follow-up appointments as directed by their doctor.
Primary Ingredients of Avomira 50mg Tablet ER
No information provided. Please provide the text you wish me to rephrase.
Uses of Avomira 50mg Tablet ER
Managing symptoms associated with overactive bladder
Major Benefits of Avomira 50mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Avomira 50mg Extended-Release Tablets. Ingest the tablet whole; do not damage it by chewing, crushing, or breaking. While Avomira 50mg ER can be administered with or without food, consistent timing is recommended.
Common Side effects of Avomira 50mg Tablet ER:
- Constipation
- Headache
- High blood pressure
- Nasal inflammation
- Urinary tract infection
- Fast heart rate
- Joint pain
How to use Avomira 50mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Avomira 50mg Extended-Release Tablet whole; do not crush, chew, or break it. While you can take it with or without food, consistent timing is recommended.
How Avomira 50mg Tablet ER works:
Avomira 50mg Extended-Release tablets contain a beta-3 adrenergic agonist that, upon binding to bladder receptors, promotes muscle relaxation. This mechanism alleviates symptoms of urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
It's recommended to avoid alcohol while taking Avomira 50mg Extended-Release Tablets. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Extended-release Avomira 50mg tablets might pose pregnancy risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Avomira 50mg tablets are likely unsafe for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Avomira 50mg Extended-Release tablets.
KidneyCAUTION
Extended-release Avomira 50mg tablets require careful administration for individuals with significant renal impairment. Dosage modification of Avomira 50mg extended-release tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Avomira 50mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult your physician. Avomira 50mg Extended-Release tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Avomira 50mg Tablet ER :
For Avomira 50mg Extended-Release Tablets, take a missed dose promptly unless your next dose is imminent. In that case, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Avomira 50mg Tablet ER
| Label | Value |
|---|---|
| Chemical Classification | Anilide-based Compound |
| Developing Habits | No. |
| Type of Treatment | Urological Care |
| Action Class | Beta-3 agonist for bladder control |
